Figure 2

The prognostic value of the signature in the TCGA cohort. (A) Kaplan–Meier survival analysis for TCGA-CRC patients with high and low risk scores. (B) Time dependent ROC curve analysis of the risk score in TCGA cohort. (C) Risk score distribution and survival status for TCGA-CRC patients in high-risk and low-risk groups. (D) Heatmap of the mitophagy related genes expression profile for TCGA-CRC patients in high-risk and low-risk groups.